194 related articles for article (PubMed ID: 12680640)
1. Prognostic value of histologic stage and proliferative activity in canine malignant mammary tumors.
Sarli G; Preziosi R; Benazzi C; Castellani G; Marcato PS
J Vet Diagn Invest; 2002 Jan; 14(1):25-34. PubMed ID: 12680640
[TBL] [Abstract][Full Text] [Related]
2. Multiparametric survival analysis of histological stage and proliferative activity in feline mammary carcinomas.
Preziosi R; Sarli G; Benazzi C; Mandrioli L; Marcato PS
Res Vet Sci; 2002 Aug; 73(1):53-60. PubMed ID: 12208107
[TBL] [Abstract][Full Text] [Related]
3. Immunocytochemical study of Ki-67 as a prognostic marker in canine mammary neoplasia.
Zuccari DA; Santana AE; Cury PM; Cordeiro JA
Vet Clin Pathol; 2004; 33(1):23-8. PubMed ID: 15048623
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Significance of Canine Mammary Tumor Histologic Subtypes: An Observational Cohort Study of 229 Cases.
Rasotto R; Berlato D; Goldschmidt MH; Zappulli V
Vet Pathol; 2017 Jul; 54(4):571-578. PubMed ID: 28355108
[TBL] [Abstract][Full Text] [Related]
5. Expression and prognostic value of c-met in canine mammary tumours.
Chen YC; Chen YY; Liao JW; Chang SC
Vet Comp Oncol; 2018 Dec; 16(4):670-676. PubMed ID: 30129270
[TBL] [Abstract][Full Text] [Related]
6. Ki-67 and PCNA Expression in Canine Mammary Tumors and Adjacent Nonneoplastic Mammary Glands: Prognostic Impact by a Multivariate Survival Analysis.
Carvalho MI; Pires I; Prada J; Lobo L; Queiroga FL
Vet Pathol; 2016 Nov; 53(6):1138-1146. PubMed ID: 27162119
[TBL] [Abstract][Full Text] [Related]
7. Rate of apoptosis in feline mammary tumors is not predictive of postsurgical survival.
Sarli G; Preziosi R; Benazzi C; Bazzo R; Mandrioli L; Marcato PS
J Vet Diagn Invest; 2003 Mar; 15(2):115-22. PubMed ID: 12661721
[TBL] [Abstract][Full Text] [Related]
8. Correlation between the histopathological diagnosis by AgNOR count and AgNOR area in canine mammary tumors.
Bundgaard-Andersen K; Flagstad A; Jensen AL; Hellmén E; Trerè D
J Vet Intern Med; 2008; 22(5):1174-80. PubMed ID: 18624984
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical detection of Ki-67 and PCNA in canine mammary tumors: relationship to clinical and pathologic variables.
Peña LL; Nieto AI; Pérez-Alenza D; Cuesta P; Castaño M
J Vet Diagn Invest; 1998 Jul; 10(3):237-46. PubMed ID: 9683072
[TBL] [Abstract][Full Text] [Related]
10. E-cadherin and beta-catenin reduction influence invasion but not proliferation and survival in canine malignant mammary tumors.
Brunetti B; Sarli G; Preziosi R; Monari I; Benazzi C
Vet Pathol; 2005 Nov; 42(6):781-7. PubMed ID: 16301574
[TBL] [Abstract][Full Text] [Related]
11. Association of argyrophilic nucleolar organizing regions, Ki-67, and proliferating cell nuclear antigen scores with histologic grade and survival in dogs with soft tissue sarcomas: 60 cases (1996-2002).
Ettinger SN; Scase TJ; Oberthaler KT; Craft DM; McKnight JA; Leibman NF; Charney SC; Bergman PJ
J Am Vet Med Assoc; 2006 Apr; 228(7):1053-62. PubMed ID: 16579784
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors for treated canine malignant lymphoma.
Kiupel M; Teske E; Bostock D
Vet Pathol; 1999 Jul; 36(4):292-300. PubMed ID: 10421095
[TBL] [Abstract][Full Text] [Related]
13. Morphometric analysis of AgNORs in tubular and papillary parts of canine mammary gland tumors.
Juntes P; Pogacnik M
Anal Quant Cytol Histol; 2000 Jun; 22(3):185-92. PubMed ID: 10872033
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the proliferation state in canine mammary tumors by the standardized AgNOR method with postfixation and immunohistologic detection of Ki-67 and PCNA.
Löhr CV; Teifke JP; Failing K; Weiss E
Vet Pathol; 1997 May; 34(3):212-21. PubMed ID: 9163877
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinase-9 expression in mammary gland tumors in dogs and its relationship with prognostic factors and patient outcome.
Santos AA; Lopes CC; Marques RM; Amorim IF; Gärtner MF; de Matos AJ
Am J Vet Res; 2012 May; 73(5):689-97. PubMed ID: 22533401
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors associated with survival two years after surgery in dogs with malignant mammary tumors: 79 cases (1998-2002).
Chang SC; Chang CC; Chang TJ; Wong ML
J Am Vet Med Assoc; 2005 Nov; 227(10):1625-9. PubMed ID: 16313041
[TBL] [Abstract][Full Text] [Related]
17. Influence of host factors on survival in dogs with malignant mammary gland tumors.
Philibert JC; Snyder PW; Glickman N; Glickman LT; Knapp DW; Waters DJ
J Vet Intern Med; 2003; 17(1):102-6. PubMed ID: 12564734
[TBL] [Abstract][Full Text] [Related]
18. Quantitation of the Regional Lymph Node Metastatic Burden and Prognosis in Malignant Mammary Tumors of Dogs.
de Araújo MR; Campos LC; Ferreira E; Cassali GD
J Vet Intern Med; 2015; 29(5):1360-7. PubMed ID: 26130166
[TBL] [Abstract][Full Text] [Related]
19. CD44 and CD24 Expression and Prognostic Significance in Canine Mammary Tumors.
Rogez B; Pascal Q; Bobillier A; Machuron F; Lagadec C; Tierny D; Le Bourhis X; Chopin V
Vet Pathol; 2019 May; 56(3):377-388. PubMed ID: 30558511
[TBL] [Abstract][Full Text] [Related]
20. Cellular proliferative and telomerase activity in canine mammary gland tumors.
Funakoshi Y; Nakayama H; Uetsuka K; Nishimura R; Sasaki N; Doi K
Vet Pathol; 2000 Mar; 37(2):177-83. PubMed ID: 10714647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
